Advertisements



AstraZeneca"s Lumoxiti Gets FDA Nod for Hairy Cell Leukemia

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

AstraZeneca Receives FDA Approval For Rare B-Cell Lymphoma Drug Lumoxiti

AstraZeneca Receives FDA Approval For Rare B-Cell Lymphoma Drug Lumoxiti.....»»

Category: topSource: seekingalphaSep 18th, 2018

Verastem Oncology Announces Collaboration With The Leukemia & Lymphoma Society To Accelerate Development Of Duvelisib For the Treatment Of Peripheral T-Cell Lymphoma

BOSTON, Mass.--(BUSINESS WIRE)-- Verastem, Inc. read more.....»»

Category: blogSource: benzingaNov 7th, 2018

AstraZeneca's Lynparza shown to put brakes on ovarian cancer - Reuters

ReutersAstraZeneca's Lynparza shown to put brakes on ovarian cancerReutersMUNICH (Reuters) - An AstraZeneca drug that blocks a cancer cell's ability to repair its g.....»»

Category: topSource: googlenewsOct 22nd, 2018

Roth Capital remains bullish on Stemline after AstraZeneca"s Lumoxiti approved

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 14th, 2018

AstraZeneca says FDA approves LUMOXITI for certain patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

FDA grants approval of HCL treatment Lumoxiti to AstraZeneca

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Johns Hopkins All Children"s becomes first Florida pediatric hospital to have unique leukemia therapy

Johns Hopkins All Children’s Hospital is now the first pediatric hospital in Florida offering a cutting-edge cellular immunotherapy for advanced leukemia in children and young adults. It will be offering CAR-T Cell Gene Therapy for leukemia. Chimer.....»»

Category: topSource: bizjournalsAug 30th, 2018

Novartis" CAR-T Therapy Kymriah Gets Approval in Europe

Novartis (NVS) gets EC approval for CAR-T therapy, Kymriah, for the treatment of pediatric and young adult patients up to 25 years of age with B-cell acute lymphoblastic leukemia. Novartis AG NVS announced that the European Commiss.....»»

Category: worldSource: nytAug 27th, 2018

AstraZeneca"s Tagrisso Wins EU Nod for First-Line Lung Cancer

AstraZeneca's (AZN) Tagrisso gets an EU nod for first-line treatment of advanced or metastatic non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) m.....»»

Category: personnelSource: nytJun 11th, 2018

Food Regulators to Share Oversight of Cell-Based Meat

U.S. food regulators agreed on a framework for regulating meat grown from animal cells, moving the emerging technology closer to consumers’ dinner plates......»»

Category: smallbizSource: wsj9 hr. 13 min. ago

Cell Tower REITs: Carriers Push Ahead On 5G

Cell Tower REITs: Carriers Push Ahead On 5G.....»»

Category: topSource: seekingalpha10 hr. 58 min. ago

Brainstorm Health: Suicide Rates, AstraZeneca Cancer Miss, Alphabet’s Glucose Lens Fail

Brainstorm Health Daily: November 16, 2018 Happy Friday, readers! In the digital health rea.....»»

Category: europeSource: fortune17 hr. 13 min. ago

AstraZeneca Shows It Can Still Take Some Knocks

Despite a failure in a drug trial, Pascal Soriot has begun to justify his decision to spurn his U.S. rival’s approach......»»

Category: topSource: washpostNov 16th, 2018

AstraZeneca reports Phase 3 MYSTIC trial did not meet primary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 16th, 2018

Cell Therapy Crossing Into Babylon?

Cell Therapy Crossing Into Babylon?.....»»

Category: topSource: seekingalphaNov 15th, 2018

International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018

International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018.....»»

Category: earningsSource: benzingaNov 15th, 2018

AstraZeneca to Sell US Rights of Lung Infection Drug to Sobi

Zacks.....»»

Category: topSource: redinewsNov 14th, 2018

AstraZeneca to Sell US Rights of Lung Infection Drug to Sobi

AstraZeneca (AZN) to sell U.S. rights of Synagis to Sobi fo.....»»

Category: personnelSource: nytNov 14th, 2018

Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA

PARP inhibitor makers get a boost following priority review for AstraZeneca???s (AZN) label expansion application for Lynparza as a first-line maintenance treatment for ovarian cancer. Shares of TESARO, Inc. TSRO and Clovis Oncology.....»»

Category: worldSource: nytNov 14th, 2018

AstraZeneca (AZN): Are Hedge Funds Right to be Bearish?

Does AstraZeneca plc (ADR) (NYSE:AZN) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest .....»»

Category: topSource: insidermonkeyNov 14th, 2018